Novo Nordisk A/S Increased Operating Profit by 18% in 2011

BAGSVAERD, DENMARK--(Marketwire - February 02, 2012) -

Sales growth of 9% driven by Victoza®, NovoRapid® and Levemir®

Company Announcement no 7 / 2012: http://hugin.info/2013/R/1581997/494216.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1581997]